Literature DB >> 18628201

Tarantula huwentoxin-IV inhibits neuronal sodium channels by binding to receptor site 4 and trapping the domain ii voltage sensor in the closed configuration.

Yucheng Xiao1, Jon-Paul Bingham, Weiguo Zhu, Edward Moczydlowski, Songping Liang, Theodore R Cummins.   

Abstract

Peptide toxins with high affinity, divergent pharmacological functions, and isoform-specific selectivity are powerful tools for investigating the structure-function relationships of voltage-gated sodium channels (VGSCs). Although a number of interesting inhibitors have been reported from tarantula venoms, little is known about the mechanism for their interaction with VGSCs. We show that huwentoxin-IV (HWTX-IV), a 35-residue peptide from tarantula Ornithoctonus huwena venom, preferentially inhibits neuronal VGSC subtypes rNav1.2, rNav1.3, and hNav1.7 compared with muscle subtypes rNav1.4 and hNav1.5. Of the five VGSCs examined, hNav1.7 was most sensitive to HWTX-IV (IC(50) approximately 26 nM). Following application of 1 microm HWTX-IV, hNav1.7 currents could only be elicited with extreme depolarizations (>+100 mV). Recovery of hNav1.7 channels from HWTX-IV inhibition could be induced by extreme depolarizations or moderate depolarizations lasting several minutes. Site-directed mutagenesis analysis indicated that the toxin docked at neurotoxin receptor site 4 located at the extracellular S3-S4 linker of domain II. Mutations E818Q and D816N in hNav1.7 decreased toxin affinity for hNav1.7 by approximately 300-fold, whereas the reverse mutations in rNav1.4 (N655D/Q657E) and the corresponding mutations in hNav1.5 (R812D/S814E) greatly increased the sensitivity of the muscle VGSCs to HWTX-IV. Our data identify a novel mechanism for sodium channel inhibition by tarantula toxins involving binding to neurotoxin receptor site 4. In contrast to scorpion beta-toxins that trap the IIS4 voltage sensor in an outward configuration, we propose that HWTX-IV traps the voltage sensor of domain II in the inward, closed configuration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18628201      PMCID: PMC2556013          DOI: 10.1074/jbc.M708447200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  muI Na+ channels expressed transiently in human embryonic kidney cells: biochemical and biophysical properties.

Authors:  C Ukomadu; J Zhou; F J Sigworth; W S Agnew
Journal:  Neuron       Date:  1992-04       Impact factor: 17.173

Review 2.  Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons.

Authors:  Anthony M Rush; Theodore R Cummins; Stephen G Waxman
Journal:  J Physiol       Date:  2006-12-07       Impact factor: 5.182

3.  Molecular interactions of the gating modifier toxin ProTx-II with NaV 1.5: implied existence of a novel toxin binding site coupled to activation.

Authors:  Jaime J Smith; Theodore R Cummins; Sujith Alphy; Kenneth M Blumenthal
Journal:  J Biol Chem       Date:  2007-03-05       Impact factor: 5.157

4.  Solution structure and alanine scan of a spider toxin that affects the activation of mammalian voltage-gated sodium channels.

Authors:  Gerardo Corzo; Jennifer K Sabo; Frank Bosmans; Bert Billen; Elba Villegas; Jan Tytgat; Raymond S Norton
Journal:  J Biol Chem       Date:  2006-12-05       Impact factor: 5.157

5.  A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity.

Authors:  Patrick L Sheets; James O Jackson; Stephen G Waxman; Sulayman D Dib-Hajj; Theodore R Cummins
Journal:  J Physiol       Date:  2007-04-12       Impact factor: 5.182

Review 6.  Voltage-gated sodium channel blockers for the treatment of neuropathic pain.

Authors:  Theodore R Cummins; Anthony M Rush
Journal:  Expert Rev Neurother       Date:  2007-11       Impact factor: 4.618

Review 7.  From genes to pain: Na v 1.7 and human pain disorders.

Authors:  Sulayman D Dib-Hajj; Theodore R Cummins; Joel A Black; Stephen G Waxman
Journal:  Trends Neurosci       Date:  2007-10-22       Impact factor: 13.837

8.  The cross channel activities of spider neurotoxin huwentoxin-I on rat dorsal root ganglion neurons.

Authors:  Meichi Wang; Xin Guan; Songping Liang
Journal:  Biochem Biophys Res Commun       Date:  2007-04-09       Impact factor: 3.575

9.  beta-Scorpion toxin modifies gating transitions in all four voltage sensors of the sodium channel.

Authors:  Fabiana V Campos; Baron Chanda; Paulo S L Beirão; Francisco Bezanilla
Journal:  J Gen Physiol       Date:  2007-08-13       Impact factor: 4.086

10.  An SCN9A channelopathy causes congenital inability to experience pain.

Authors:  James J Cox; Frank Reimann; Adeline K Nicholas; Gemma Thornton; Emma Roberts; Kelly Springell; Gulshan Karbani; Hussain Jafri; Jovaria Mannan; Yasmin Raashid; Lihadh Al-Gazali; Henan Hamamy; Enza Maria Valente; Shaun Gorman; Richard Williams; Duncan P McHale; John N Wood; Fiona M Gribble; C Geoffrey Woods
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

View more
  81 in total

1.  The tarantula toxins ProTx-II and huwentoxin-IV differentially interact with human Nav1.7 voltage sensors to inhibit channel activation and inactivation.

Authors:  Yucheng Xiao; Kenneth Blumenthal; James O Jackson; Songping Liang; Theodore R Cummins
Journal:  Mol Pharmacol       Date:  2010-09-20       Impact factor: 4.436

2.  Venom: the sharp end of pain therapeutics.

Authors:  Steven A Trim; Carol M Trim
Journal:  Br J Pain       Date:  2013-11

3.  Analysis of the structural and molecular basis of voltage-sensitive sodium channel inhibition by the spider toxin huwentoxin-IV (μ-TRTX-Hh2a).

Authors:  Natali A Minassian; Alan Gibbs; Amy Y Shih; Yi Liu; Robert A Neff; Steven W Sutton; Tara Mirzadegan; Judith Connor; Ross Fellows; Matthew Husovsky; Serena Nelson; Michael J Hunter; Mack Flinspach; Alan D Wickenden
Journal:  J Biol Chem       Date:  2013-06-12       Impact factor: 5.157

4.  Gating modifier toxins isolated from spider venom: Modulation of voltage-gated sodium channels and the role of lipid membranes.

Authors:  Akello J Agwa; Steve Peigneur; Chun Yuen Chow; Nicole Lawrence; David J Craik; Jan Tytgat; Glenn F King; Sónia Troeira Henriques; Christina I Schroeder
Journal:  J Biol Chem       Date:  2018-04-27       Impact factor: 5.157

Review 5.  Sodium channel blockers for the treatment of neuropathic pain.

Authors:  Anindya Bhattacharya; Alan D Wickenden; Sandra R Chaplan
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 6.  Subtype-selective targeting of voltage-gated sodium channels.

Authors:  Steve England; Marcel J de Groot
Journal:  Br J Pharmacol       Date:  2009-10-20       Impact factor: 8.739

7.  Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNav1.7.

Authors:  Robert A Neff; Mack Flinspach; Alan Gibbs; Amy Y Shih; Natali A Minassian; Yi Liu; Ross Fellows; Ondrej Libiger; Stephanie Young; Michael W Pennington; Michael J Hunter; Alan D Wickenden
Journal:  J Biol Chem       Date:  2019-12-23       Impact factor: 5.157

Review 8.  Use of venom peptides to probe ion channel structure and function.

Authors:  Sébastien Dutertre; Richard J Lewis
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

9.  Structure-function map of the receptor site for β-scorpion toxins in domain II of voltage-gated sodium channels.

Authors:  Joel Z Zhang; Vladimir Yarov-Yarovoy; Todd Scheuer; Izhar Karbat; Lior Cohen; Dalia Gordon; Michael Gurevitz; William A Catterall
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

Review 10.  The insecticidal potential of venom peptides.

Authors:  Jennifer J Smith; Volker Herzig; Glenn F King; Paul F Alewood
Journal:  Cell Mol Life Sci       Date:  2013-03-23       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.